High Grip Strength Associated With Lower Risk for Diabetes-Related AEs
Study conclusion needs to be tested in future well-designed randomized controlled trials.
Abatacept conferred a greater reduction in cardiovascular risk compared with tumor necrosis factor inhibitors in patients with rheumatoid arthritis and diabetes.
New recommendations have been developed for the prevention, detection, evaluation, and management of high blood pressure.
In patients with an acute coronary syndrome and LDL-C >50 mg/dL, healthcare providers should consider adding ezetimibe to statin therapy to reduce the risk of cardiovascular events.